Skip to content
home button
Search

A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.

LEARN MORE
search button
  • Home
  • About
    • Thought Leadership
    • Spotlight on Clinical Trial Sites
    • Spotlight on Mentees
    • ARLG Scientific Agenda
  • Publications
  • News and Events
    • Events
    • Newsletters
  • How to Apply
    • Biorepository Request
    • Protocol Concept
    • Early Stage Investigator (ESI) Grants
    • The Dr. John G. Bartlett ARLG Fellowship
    • Clinical Trial Sites
    • Adjudicator Request
    • Industry Collaborations
    • Request Data
  • SDMC
  • Lab Center
    • About the Laboratory Center
    • ARLG Biorepository
    • FAQs
  • Studies
  • Resources
    • For Patients and the Community
    • Summary of Results

ARLG

Antibacterial Resistance Leadership Group

September 2019

Posted on October 10, 2019October 20, 2020 by patty.mcadams@duke.edu

Our September 2019 newsletter includes information about the MASTER-GC Study and the Pharmacokinetics Special Emphasis Panel. We also provide a spotlight on early-career trialist, Thomas L. Holland, MD, MSc of Duke University. ARLG’s presence at IDWeek2019 is included as well as recent announcements and publications.

 

This entry was posted in Newsletter, Uncategorized. Bookmark the permalink.

Post navigation

← ARLG at IDWeek 2019
Practical efforts to curb antibiotic prescriptions could have large effect in small hospitals →
  • Home
  • About the ARLG
  • Publications
  • About the Laboratory Center
  • Studies
ARLG is supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Subscribe to the ARLG newsletter to stay connected

Contact Us
 
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.